Optimer Pharmaceuticals, Inc. (OPTR)
$11.89
-0.11 (-0.92%)
| CAPS Rating |
|
|---|---|
| Open | $12.04 |
| Previous Close | $12.00 |
| Daily Range | $11.71 - $12.32 |
| 52-Week Range | $6.86 - $15.17 |
| Market Cap | $393.6M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 148,728 |
| Average Daily Volume | 205,000 |
OPTR
VS S&P 500 (SPY)
How do you think OPTR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OPTR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OPTR News and Commentary
- Get Ready for the Fall – The Motley Fool
- Why We Love Wild Penny Stocks – The Motley Fool
Related News and Articles
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Government Won't Be There for You – The Motley Fool
- Your Heart or Your Stomach? – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- VIVUS Gets a Spark – The Motley Fool
- Can This Stock Go Higher? – The Motley Fool
- 5 Stocks Making Cash – The Motley Fool
- Dividends for 100 Years – The Motley Fool
- Up 80%, It's Time to Sell – The Motley Fool
- This Partnership Is Smoking! – The Motley Fool
- A Big Upgrade for Sanofi-Aventis – The Motley Fool
RSS Headlines
Fool UK
